H1 is the first company to arm healthcare and life science companies with on-demand, live insights from across the data universe to accelerate the discovery and development of therapies to fight diseases.
H1 enables industry, healthcare organizations, and healthcare professionals to connect with each other like never before.
H1 Insights was founded in 2017 by Ariel Katz and Ian SaxIan Sax. The company is headquartered in New York, New York.
H1 Insights provides real-time data to support the end-to-end therapeutic development process from fundraising to product development to product launch, helping companies make smarter scientific decisions.
H1’s platform comprises over 8 million researcher, physician, pharmacist, nurse, and administrator profiles across 70 countries, 16,000 health care organizations, 160 million peer-reviewed publications (and citation counts), 350,000 clinical trials, 2 billion procedures, 3 billion diagnoses, 700 medical societies, and proprietary scholarly metrics that are kept up to date weekly.
H1 Insights is backed by Menlo Ventures, Y Combinator, Novartis DRX, Baron Davis Enterprises, ClearPoint Investment and others. The company raised $12.9M in a Series A round on Apr 22, 2020. This brings H1's total funding to $18.9M to date.